Ireland United KingdomFranceSwitzerlandAustriaDeutschlandSwitzerlandItalianSwitzerlandSpanishEnglishChinaEnglishEnglishEnglishAustriaSwitzerland

Breathing life into medicines

Supply News

ImmuCyst 81mg is now available

Key ImmuCyst supporting materials, for use by UK healthcare professionals, can be viewed and ordered here.

At Alliance, we work extremely hard to maintain supply of our products but despite our best efforts there are occasions when we experience interruptions to supply. We fully understand the importance of our products and are committed to working to resolve these issues as quickly as possible.

If you are a UK healthcare professional and you require further information on the supply of one of our products please contact our customer services team via our switchboard on +44 (0) 1249 466966. For any other product related enquiries, please contact our Medical Information team.

The information contained on this page is intended for UK healthcare professionals. If you are a patient and you are concerned about how an interruption to supply may affect you, we recommend that you consult your doctor.

We have divested the following products:

  • Syntocinon® 5IU/ml and 10IU/ml concentrate for solution for infusion - Please contact Novartis Pharmaceuticals
  • Sinthrome® Tablets 1mg - Please contact Novartis Pharmaceuticals
  • Synacthen® Ampoules 250 mcg - Please contact the Mallinckrodt Medical Information Team  +44 (0) 1423 852982
  • Synacthen® Depot Amploule 1mg/ml - Please contact the Mallinckrodt Medical Information Team  +44 (0) 1423 852982

We have discontinued the following products:

  • Slow-K® 600mg Tablets                            
  • Calcium-Sandoz® Syrup
  • Forceval® Junior Capsules
  • Meted® 3% & 5% w/w Shampoo
  • Pentrax® 4.3% w/v Shampoo
  • Hygroton® 50mg Tablets
  • Pavacol-D® 5mg/5ml 150ml Bottle
  • Distamine® 250mg Tablets
  • Distamine® 125mg Tablets
  • Deltacortil® 2.5mg Tablets
  • Deltacortil® 5mg Tablets
  • Aquidose Aqua® 240ml Bottle

Adverse events (side effects) thought to have been caused by one of our products should be reported to the MHRA via their yellow card scheme and to Alliance’s Pharmacovigilance team. Click here to submit a report